Tag: phase-3-trial

Oct 05, 2026

• cancer
• vaccine
• mRNA
• melanoma
• adjuvant-therapy
• keytruda
• moderna
• merck
• mRNA-vaccine
• neoantigen
• phase-3-trial

Oct 04, 2026

• phase-3-trial
• clinical-trials
• moderna
• merck
• mrna-vaccine
• melanoma
• adjuvant-therapy
• regulatory-approval

Sep 26, 2026

• mrna-vaccine
• melanoma
• moderna
• merck
• keytruda
• adjuvant-therapy
• phase-3-trial
• intismeran-autogene